Recombinant Zika Virus Envelope protein (a.a 593- 699) [His]

Target

E protein

Nature

Recombinant

Tag/Conjugate

His

Molecular Weight

13 kDa

Alternative Names

ZIKV-E; Envelope protein; Zika virus envelope protein

Purity

> 95% , as determined by SDS-PAGE

Format

Lyophilized Powder

Buffer

20 mM Tris, 500 mM NaCl, pH 8.0, 10 % glycerol

Preservative

None

Storage

Store at -20°C to -80°C. Avoid multiple freeze/thaw cycles

Introduction

Zika virus is an emerging disease that is spread by Aedes mosquitoes. The virus was first isolated in Central Africa, and has since been spread to South Asia and recently to South America. Zika virus can cause mild fever, rash, myalgia, arthralgia and headaches, with one in four infected individuals being asymptomatic. Due to similar symptoms Zika virus infected individuals can easily be mis-diagnosed as a dengue infection and vice-versa. In addition, Zika virus has been implicated in causing microcephaly through transmission in utero.

Antigen Description

A DNA sequence encoding the Zika virus (strain Zika SPH2015) E / Envelope (domain III) (ALU33341.1) (Val593-Lys699) was expressed with a polyhistidine tag at the C-terminus.

Keywords

Zika virus; ZIKV; Envelope protein